Back
Dianthus Therapeutics, Inc. Stock Price Chart
Exxon and Chevron Have an Unlikely New Competitor
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at
Buy
75
DNTH
Dianthus Therapeutics, Inc.
Last Price:
$44.76
Seasonality Move:
32.46%
7 Day Trial
ALL ACCESS PASS
$
7
Meet America's Newest $1B Unicorn
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DNTH is experiencing buying pressure, which is a positive indicator for future bullish movement.
Dianthus Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 39.09 | Buy |
| 20-day SMA: | 40.88 | Buy |
| 50-day SMA: | 40.39 | Buy |
| 200-day SMA: | 28.05 | Buy |
| 8-day EMA: | 40.25 | Buy |
| 20-day EMA: | 40.58 | Buy |
| 50-day EMA: | 39.7 | Buy |
| 200-day EMA: | 31.69 | Buy |
Dianthus Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.32 | Sell |
| Relative Strength Index (14 RSI): | 63.89 | Buy |
| Chaikin Money Flow: | 1054693 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (39.07 - 43.67) | Buy |
| Bollinger Bands (100): | (31.06 - 42.48) | Buy |
Dianthus Therapeutics, Inc. Technical Analysis
| Dec 29 | Dec 30 | Dec 31 | Jan 5 | Jan 6 | Jan 7 | Jan 8 | Jan 9 | Jan 12 | Jan 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 29 | 30 | 31 | 05 | 06 | 07 | 08 | 09 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Dianthus Therapeutics, Inc. Stock
Is Dianthus Therapeutics, Inc. Stock a Buy?
-
Dianthus Therapeutics, Inc. share price is 44.86 while DNTH 8-day simple moving average is 39.09, which is a Buy signal.
-
The stock price of DNTH is 44.86 while Dianthus Therapeutics, Inc. 20-day SMA is 40.88, which makes it a Buy.
-
Dianthus Therapeutics, Inc. 50-day simple moving average is 40.39 while DNTH share price is 44.86, making it a Buy technically.
-
DNTH stock price is 44.86 and Dianthus Therapeutics, Inc. 200-day simple moving average is 28.05, creating a Buy signal.
DNTH Technical Analysis vs Fundamental Analysis
Buy
75
Dianthus Therapeutics, Inc. (DNTH)
is a Buy
Is Dianthus Therapeutics, Inc. a Buy or a Sell?
-
Dianthus Therapeutics, Inc. stock is rated a BuyThe current Dianthus Therapeutics, Inc. [DNTH] share price is $44.86. The Score for DNTH is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
Dianthus Therapeutics, Inc. Stock Info
Market Cap:
1.9B
Price in USD:
44.86
Share Volume:
1.7M
Dianthus Therapeutics, Inc. 52-Week Range
52-Week High:
46.22
52-Week Low:
13.37
Buy
75
Dianthus Therapeutics, Inc. (DNTH)
is a Buy
Dianthus Therapeutics, Inc. Share Price Forecast
-
What is the Dianthus Therapeutics, Inc. stock price today?The Dianthus Therapeutics, Inc. stock price is 44.86 USD today.
-
Will DNTH stock go up or go down?Dianthus Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Dianthus Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Dianthus Therapeutics, Inc. is not overvalued.
Is Dianthus Therapeutics, Inc. Stock a Buy?
-
Dianthus Therapeutics, Inc. share price is 44.86 while DNTH 8-day exponential moving average is 40.25, which is a Buy signal.
-
The stock price of DNTH is 44.86 while Dianthus Therapeutics, Inc. 20-day EMA is 40.58, which makes it a Buy.
-
Dianthus Therapeutics, Inc. 50-day exponential moving average is 39.70 while DNTH share price is 44.86, making it a Buy technically.
-
DNTH stock price is 44.86 and Dianthus Therapeutics, Inc. 200-day simple moving average is 31.69, creating a Buy signal.
Fundamental Analysis of Dianthus Therapeutics, Inc.
Is Dianthus Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.14 per share, and a decrease next year of $0.43 per share.
Technical Analysis of Dianthus Therapeutics, Inc.
Should I short Dianthus Therapeutics, Inc. stock?
-
DNTH Moving Average Covergence Divergence (MACD) indicator is -0.32, suggesting Dianthus Therapeutics, Inc. is a Sell
-
Dianthus Therapeutics, Inc. Relative Strength Index (RSI) is 63.89, which suggest Dianthus Therapeutics, Inc. is overbought
-
The Bollinger Bands (25) for Dianthus Therapeutics, Inc. is (39.07 - 43.67), which suggest Dianthus Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Dianthus Therapeutics, Inc. is (31.06 - 42.48), which suggest Dianthus Therapeutics, Inc. is a Buy
* Dianthus Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.